Search

Yujun Hao

from Cleveland, OH
Age ~45
Get Report
Also known as:
Yu J Hao
Related to:
Vivian Ling Chou, 63Tsu Chang Wang, 84Michael WangYan Wang, 52Mu C Wang, 70Y Wang, 44Ju Wang Yi, 44Peng Wang, 43Li C Wang, 57Yinglu Wang, 44Youkun WangMu C Wang, 57Yiwei Wang, 59Yan Wang, 52Wei Wang, 44Yibo WangYunzheng Wang, 33Yi Ju Wang, 43
Connected to:
Cen Hao, 45Eileen Hao, 36Gang Hao, 58Hexia K Hao, 64Jeff Y Hao, 42Jie Hao, 57Jun Hao, 61Junsheng Hao, 44Ken H Hao, 39Kevin Z Hao, 41

Yujun Hao Phones & Addresses

  • Cleveland, OH

Work

Company: Case western reserve university Position: Postdoc

Industries

Higher Education

Resumes

Resumes

Yujun Hao Photo 1

Postdoc

View page
Location:
Cleveland, OH
Industry:
Higher Education
Work:
Case Western Reserve University
Postdoc

Publications

Us Patents

Compositions And Methods For Inhibiting The Activity Of P110A Mutant Proteins

View page
US Patent:
20140005119, Jan 2, 2014
Filed:
Jun 28, 2013
Appl. No.:
13/931263
Inventors:
Yujun Hao - Cleveland Heights OH, US
Chao Wang - Singapore, SG
Weiping Zheng - Zhenjiang City, CN
International Classification:
C12N 9/12
US Classification:
514 193, 435184
Abstract:
A method of inhibiting the activity, signaling, and/or function of a p110α mutant protein in a cancer cell expressing the p110α mutant protein includes administering to the cancer cell an amount of a therapeutic agent effective to inhibit binding of the p110α mutant protein to IRS1 in the cell.

Compositions And Methods Of Treating Cancer Harboring Pikc3A Mutations

View page
US Patent:
20160010158, Jan 14, 2016
Filed:
May 13, 2015
Appl. No.:
14/711507
Inventors:
- CLEVELAND OH, US
Yujun Hao - Cleveland Heights OH, US
International Classification:
C12Q 1/68
A61K 31/501
A61K 31/195
A61K 31/433
G01N 33/574
A61K 31/353
Abstract:
A method of treating cancer cells having mutated PIK3CA gene or protein of a subject in need thereof includes administering to the subject a therapeutically effective amount of an inhibitor of one or more enzymes of the glutamine metabolism pathway.

Targeted Gene Modification Using Hybrid Recombinant Adeno-Associated Virus

View page
US Patent:
20140359799, Dec 4, 2014
Filed:
Dec 24, 2012
Appl. No.:
14/366605
Inventors:
- Cleveland OH, US
Xiujing Feng - Cleveland OH, US
Peng Zhang - Cleveland OH, US
Yujun Hao - Cleveland OH, US
International Classification:
C12N 15/86
US Classification:
800 21, 435456
Abstract:
An in vitro method of producing a mouse cell having a genetic modification at a preselected genomic target locus includes transducing into the mouse cell an effective amount of a hybrid recombinant adeno-associated virus (AAV) vector that includes an AAV targeting construct of a first serotype packaged with a variant AAV capsid protein different than a capsid protein of the first serotype.
Control profile
Yujun Hao from Cleveland, OH, age ~45 Get Report